RedHill Biopharma (RDHL) Long-Term Deferred Tax (2017 - 2020)
RedHill Biopharma's (RDHL) quarterly Long-Term Deferred Tax came in at $1.2 million in Q1 2020, down 88.17% on a QoQ basis from $10.0 million in Q4 2017.
RedHill Biopharma (RDHL) Long-Term Deferred Tax (2017 - 2020) Analysis & Trends
RedHill Biopharma (RDHL) has 2 years of Long-Term Deferred Tax data on file, last reported at $1.2 million in Q1 2020.
- On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $1.2 million in Q1 2020; TTM through Mar 2020 was $1.2 million, a N/A change from a year earlier, with the FY2017 full-year figure at $10.0 million, changed N/A from the prior year.
- Long-Term Deferred Tax for Q1 2020 stood at $1.2 million, down from $10.0 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for RDHL reached as high as $10.0 million in Q4 2017 and fell as low as $1.2 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.18 Mn |
| Dec 31, 2017 | 10.00 Mn |